YayaNews LogoYaya Financial News
美股Neutral

Insight Molecular Diagnostics Q2 2026 Earnings Preview

IMDX Q2 earnings are due Aug 10 after close. See consensus EPS -$0.25 and revenue $0.44M, plus beat history, to prepare your trade now.

Financial news writerUpdated: 4 ViewsSource Seeking Alpha

YayaNews contributes financial news and market context through the YayaNews editorial workflow.

Insight Molecular Diagnostics Q2 2026 Earnings Preview
Image Source: Seeking Alpha

IMDX Q2 earnings are due Aug 10 after close. See consensus EPS -$0.25 and revenue $0.44M, plus beat history, to prepare your trade now.

Insight Molecular Diagnostics Q2 2026 Earnings Preview | Seeking Alpha

Insight Molecular Diagnostics Inc. (

IMDX

) is scheduled to announce Q2 earnings results on Monday, August 10th, after market close.

The consensus

EPS estimate is -$0.25,

and the consensus revenue estimate is $0.44M

Over the last year, IMDX

has beaten EPS

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.

Is this happening to you frequently? Please

report it on our feedback forum.

If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.

Search field

Entering text into the input field will update the search result below

Recommended For You

More

Trending News

See More

»

Disclaimer

Original YayaNews editorial coverage, published for informational purposes.

This article is sourced from Seeking Alpha. It is for informational purposes only and does not constitute investment advice.

Share

Topics & Symbols

Topics & symbols

Continue Reading

Previous & next

Related Reading

Go to Channel